1. Sohn BS, Kim J, Kim M, et al. Treatment outcomes of advanced/metastatic extramammary Paget's disease in Korean patients: KCSG-RC20-06. Cancer Med 2023;12:15159-75.
2. Park SE, Kim DH, Kim DK, et al. Feasibility and safety of exercise during chemotherapy in people with gastrointestinal cancers: a pilot study. Support Care Cancer 2023;31:561.
3. Kim JE, Park SE, Kim HJ, Hwang IG. Clinical Implication of DNA Damage Response Genes in Advanced Gastric Cancer Stage IV and Recurrent Gastric Cancer Patients After Gastrectomy Treated Palliative Chemotherapy. J Cancer 2023;14:1216-22.
4. Park SE, Kim HS, Jung EJ, et al. Low PARP-1 expression level is an indicator of poor prognosis in patients with stage II and III gastric cancer. J Cancer 2022;13:869-76.
5. Kim H, Kim DW, Kim M, et al. Long-term outcomes in patients with advanced and/or metastatic non-small cell lung cancer who completed 2 years of immune checkpoint inhibitors or achieved a durable response after discontinuation without disease progression: Multicenter, real-world data (KCSG LU20-11). Cancer 2022;128:778-87.
6. Park SE, Choi JH, Park JY, et al. Loss of skeletal muscle mass during palliative chemotherapy is a poor prognostic factor in patients with advanced gastric cancer. Sci Rep 2020;10:17683.
7. Hong J, Kim Y, Cho J, et al. Clinical features and prognosis of breast cancer with gastric metastasis. Oncol Lett 2019;17:1833-41.
8. Park SE, Hwang JH, Choi JH, et al. Incidence, Risk Factors, and Clinical Outcomes of Acute Kidney Injury Caused by Palliative Chemotherapy in Lung Cancer. J Cancer 2019;10:5332-8.
9. Park SE, Choi JH, Choi CH, et al. Additional Chemotherapy with 5-FU plus Leucovorin between Preoperative Chemoradiotherapy and Surgery Improved Treatment Outcomes in Patients with Advanced Rectal Cancer. J Cancer 2019;10:186-91.
10. Kim HK, Park KH, Kim Y, et al. Discordance of the PAM50 Intrinsic Subtypes Compared with Immunohistochemistry-Based Surrogate in Breast Cancer Patients: Potential Implication of Genomic Alterations of Discordance. Cancer Res Treat 2019;51:737-47.
11. Kim HK, Lee SH, Kim YJ, et al. Does guideline non-adherence result in worse clinical outcomes for hormone receptor-positive and HER2-negative metastatic breast cancer in premenopausal women?: result of an institution database from South Korea. BMC Cancer 2019;19:84.
12. Park SE, Noh JM, Kim YJ, et al. EGFR Mutation Is Associated with Short Progression-Free Survival in Patients with Stage III Non-squamous Cell Lung Cancer Treated with Concurrent Chemoradiotherapy. Cancer Res Treat 2019;51:493-501.
13. Lee H, Lee HY, Sun JM, et al. Transient Asymptomatic Pulmonary Opacities During Osimertinib Treatment and its Clinical Implication. J Thorac Oncol 2018;13:1106-12.
14. Park SE, Park K, Lee E, et al. Clinical implication of tumor mutational burden in patients with HER2-positive refractory metastatic breast cancer. Oncoimmunology 2018;7:e1466768.
15. Lim SW, Park S, Kim Y, et al. Continuation of gefitinib beyond progression in patients with EGFR mutation-positive non-small-cell lung cancer: A phase II single-arm trial. Lung Cancer 2018;124:293-7.
16. Ha JY, Park SE, Kim HS, Won H, Kim BJ, Hwang IG. A case report of recurrent Merkel cell carcinoma with synchronous metastases to the heart and stomach. Medicine (Baltimore) 2018;97:e13032.
17. Park SE, Lee SH, Ahn JS, Ahn MJ, Park K, Sun JM. Increased Response Rates to Salvage Chemotherapy Administered after PD-1/PD-L1 Inhibitors in Patients with Non-Small Cell Lung Cancer. J Thorac Oncol 2018;13:106-11.
18. Park SE, Hwang IG, Choi CH, et al. Sarcopenia is poor prognostic factor in older patients with locally advanced rectal cancer who received preoperative or postoperative chemoradiotherapy. Medicine (Baltimore) 2018;97:e13363.
19. Lee HY, Hwang IG, Park SE, et al. Factors Influencing Clinicians' Choice of Adjuvant S-1 versus Capecitabine plus Oxaliplatin after Curative Gastrectomy in Patients with Gastric Cancer. J Cancer 2016;7:1711-5.
20. Kim YS, Hwang IG, Park SE, et al. Role of adjuvant therapy after R0 resection for patients with distal cholangiocarcinoma. Cancer Chemother Pharmacol 2016;77:979-85.
21. Park SE, Choi CW, Kwon MS, Tae JH, Kim HJ. Spontaneous tumour lysis syndrome with follicular lymphoma. Br J Hosp Med (Lond) 2015;76:172-3.